Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1173062rdf:typepubmed:Citationlld:pubmed
pubmed-article:1173062lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:1173062lifeskim:mentionsumls-concept:C0014792lld:lifeskim
pubmed-article:1173062lifeskim:mentionsumls-concept:C0000854lld:lifeskim
pubmed-article:1173062lifeskim:mentionsumls-concept:C0370058lld:lifeskim
pubmed-article:1173062lifeskim:mentionsumls-concept:C0003372lld:lifeskim
pubmed-article:1173062lifeskim:mentionsumls-concept:C1516084lld:lifeskim
pubmed-article:1173062pubmed:issue1lld:pubmed
pubmed-article:1173062pubmed:dateCreated1975-6-19lld:pubmed
pubmed-article:1173062pubmed:abstractTextAfter repeated, 10-20 absorptions of ALS with one-half of its volume of unwashed human erythrocytes, performed each time for 30 min. at room temperature, the titres of the undesired thrombo-agglutinins and thrombolysins can be reduced or these antibodies can be eliminated from ALS. After absorption anticomplementarity of ALS increases and the lymphocytotoxin titre declines. The optimal number of absorptions which would not reduce markedly the immunosuppressive activity of ALS remains to be determined.lld:pubmed
pubmed-article:1173062pubmed:languageenglld:pubmed
pubmed-article:1173062pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1173062pubmed:citationSubsetIMlld:pubmed
pubmed-article:1173062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1173062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1173062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1173062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1173062pubmed:statusMEDLINElld:pubmed
pubmed-article:1173062pubmed:issn0015-5500lld:pubmed
pubmed-article:1173062pubmed:authorpubmed-author:FialaJJlld:pubmed
pubmed-article:1173062pubmed:authorpubmed-author:MájskýAAlld:pubmed
pubmed-article:1173062pubmed:authorpubmed-author:BednaríkTTlld:pubmed
pubmed-article:1173062pubmed:issnTypePrintlld:pubmed
pubmed-article:1173062pubmed:volume21lld:pubmed
pubmed-article:1173062pubmed:ownerNLMlld:pubmed
pubmed-article:1173062pubmed:authorsCompleteYlld:pubmed
pubmed-article:1173062pubmed:pagination75-8lld:pubmed
pubmed-article:1173062pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:1173062pubmed:meshHeadingpubmed-meshheading:1173062-...lld:pubmed
pubmed-article:1173062pubmed:meshHeadingpubmed-meshheading:1173062-...lld:pubmed
pubmed-article:1173062pubmed:meshHeadingpubmed-meshheading:1173062-...lld:pubmed
pubmed-article:1173062pubmed:meshHeadingpubmed-meshheading:1173062-...lld:pubmed
pubmed-article:1173062pubmed:meshHeadingpubmed-meshheading:1173062-...lld:pubmed
pubmed-article:1173062pubmed:meshHeadingpubmed-meshheading:1173062-...lld:pubmed
pubmed-article:1173062pubmed:meshHeadingpubmed-meshheading:1173062-...lld:pubmed
pubmed-article:1173062pubmed:meshHeadingpubmed-meshheading:1173062-...lld:pubmed
pubmed-article:1173062pubmed:meshHeadingpubmed-meshheading:1173062-...lld:pubmed
pubmed-article:1173062pubmed:meshHeadingpubmed-meshheading:1173062-...lld:pubmed
pubmed-article:1173062pubmed:meshHeadingpubmed-meshheading:1173062-...lld:pubmed
pubmed-article:1173062pubmed:meshHeadingpubmed-meshheading:1173062-...lld:pubmed
pubmed-article:1173062pubmed:year1975lld:pubmed
pubmed-article:1173062pubmed:articleTitleAn attempt to eliminate platelet antibodies from antilymphocyte serum (ALS) by absorption with unwashed human erythrocytes.lld:pubmed
pubmed-article:1173062pubmed:publicationTypeJournal Articlelld:pubmed